Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
Jason Kelce opens about wife Kylie Kelce's past pregnancy loss- Carry Nature Inside with These Staggering Plant Decisions
- SUVs Known for Their Looks As opposed to Their Capacity
- Surging measles cases are 'fire alarm' warning that other diseases could be next
- Full Supreme Court to hear challenge to Judicial Selection Committee law
- Former Peruvian President Pedro Castillo sentenced for conspiracy
- Sunken warship found off Danish coast after 225 years in ‘remarkable’ discovery
- Extraordinary Picks for Home Apparatuses: Making Life Simpler
- SpaceX rocket launches 140 satellites into orbit on Transporter-15, aces landing at sea (video)
